OrbiMed Israel GP Ltd.
Insider CIK 1569590 · NVUS Director, 10% owner · CMMB 10% owner · NMTR Director, 10% owner · ACET Director, 10% owner · PHGE Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 40,416 | $6.52 | $263.5K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 32,523 | $6.29 | $204.6K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 2,400 | $6.38 | $15.3K | 32,523 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 29,319 | $6.53 | $191.5K | 34,923 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 3,500,000 | $1.00 | $3.50M | 4,490,254 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 1,500,000 | $1.00 | $1.50M | 9,026,359 | SEC↗ |
| PHGE BiomX Inc. | X Exercise deriv | 2024-05-15 | 2024-05-20 | 9,280,408 | — | $0 | 0 | SEC↗ |
| PHGE BiomX Inc. | X Exercise | 2024-05-15 | 2024-05-20 | 9,280,408 | $0.24 | $2.23M | 13,797,997 | SEC↗ |
| PHGE BiomX Inc. | S Sale | 2024-05-15 | 2024-05-20 | 24,344 | $0.38 | $9.3K | 13,773,653 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2024-03-15 | 2024-03-19 | 4,327 | — | $0 | 4,327 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2024-03-15 | 2024-03-19 | 2,163,500 | — | $0 | 2,163,500 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,841,100 | $2.40 | $4.42M | 7,526,359 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,041,700 | $2.40 | $2.50M | 1,255,985 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 242,200 | $2.40 | $581.3K | 990,254 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 125,000 | $2.09 | $261.2K | 1,027,885 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 250,000 | $2.09 | $522.5K | 646,657 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 442,000 | $2.09 | $923.8K | 5,685,259 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 58,000 | $2.09 | $121.2K | 748,054 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2023-02-27 | 2023-03-17 | 1,789,959 | — | $0 | 1,789,959 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2023-02-27 | 2023-03-17 | 348,000 | $0.25 | $87.0K | 3,161,489 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2023-01-03 | 2023-01-05 | 266,376 | $3.34 | $889.7K | 2,311,798 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2023-01-03 | 2023-01-05 | 70,524 | $4.51 | $318.1K | 2,241,274 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-12-10 | 2021-12-14 | 214,285 | $14.00 | $3.00M | 242,285 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2021-07-28 | 2021-07-30 | 375,000 | — | $0 | 375,000 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2021-07-28 | 2021-07-30 | 500,000 | — | $0 | 2,813,489 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | S Sale | 2021-06-25 | 2021-06-25 | 15,989,876 | $1.21 | $19.35M | 8,565,974 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | S Sale | 2021-06-24 | 2021-06-25 | 319,255 | $1.38 | $440.6K | 24,555,850 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | S Sale | 2021-06-23 | 2021-06-25 | 841,650 | $1.36 | $1.14M | 24,875,105 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | X Exercise deriv | 2021-05-11 | 2021-05-13 | 12,500 | — | $0 | 37,500 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | X Exercise deriv | 2021-05-11 | 2021-05-13 | 19,444 | — | $0 | 80,556 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | X Exercise | 2021-05-11 | 2021-05-13 | 12,500 | $0.70 | $8.8K | 25,729,255 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | X Exercise | 2021-05-11 | 2021-05-13 | 19,444 | $0.62 | $12.1K | 25,748,699 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-03-16 | 2021-03-18 | 28,817 | — | $0 | 28,817 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award | 2021-03-16 | 2021-03-18 | 288,170 | $17.35 | $5.00M | 2,578,174 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 420,299 | $13.00 | $5.46M | 5,243,259 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 104,050 | $13.00 | $1.35M | 396,657 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 103,200 | $21.60 | $2.23M | 73,650 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | J Other | 2020-10-30 | 2020-11-03 | 1,943,734 | — | $0 | 25,716,755 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 292,607 | — | $0 | 292,607 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 902,885 | — | $0 | 902,855 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 4,822,960 | — | $0 | 4,822,960 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 67,865 | — | $0 | 0 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion | 2020-06-30 | 2020-07-02 | 6,786,500 | — | $0 | 23,773,021 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | P Buy deriv | 2020-05-04 | 2021-03-19 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | P Buy deriv | 2020-05-04 | 2021-03-19 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award | 2020-04-30 | 2021-03-19 | 18,930,255 | — | $0 | 18,930,255 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2020-04-30 | 2020-05-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale deriv | 2020-01-14 | 2020-02-25 | 646,204 | $0.20 | $129.2K | 0 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale deriv | 2020-01-14 | 2020-02-25 | 646,204 | $0.20 | $129.2K | 0 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-19 | 2019-12-20 | 3,500 | $8.90 | $31.1K | 2,313,489 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-18 | 2019-12-20 | 500 | $8.93 | $4.5K | 2,309,989 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-11 | 2019-12-12 | 5,400 | $8.92 | $48.2K | 2,309,489 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-10 | 2019-12-12 | 3,400 | $8.75 | $29.8K | 2,304,089 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-09 | 2019-12-09 | 6,000 | $8.68 | $52.1K | 2,300,689 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-06 | 2019-12-09 | 800 | $8.00 | $6.4K | 2,294,689 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2019-12-05 | 2019-12-09 | 3,400 | $7.99 | $27.2K | 2,293,889 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy deriv | 2019-05-02 | 2019-05-06 | 646,204 | — | $0 | 646,204 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy deriv | 2019-05-02 | 2019-05-06 | 646,204 | — | $0 | 646,204 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2019-05-02 | 2019-05-06 | 646,204 | $3.10 | $2.00M | 3,183,314 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award | 2017-05-09 | 2017-05-11 | 2,537,110 | — | $0 | 2,537,110 | SEC↗ |